These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11557302)

  • 21. Behavioral consequences of repeated nicotine during adolescence in alcohol-preferring AA and alcohol-avoiding ANA rats.
    Kemppainen H; Hyytiä P; Kiianmaa K
    Alcohol Clin Exp Res; 2009 Feb; 33(2):340-9. PubMed ID: 19032573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with naltrexone.
    Zalewska-Kaszubska J; Gorska D; Dyr W; Czarnecka E
    Physiol Behav; 2008 Mar; 93(4-5):1005-10. PubMed ID: 18262210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats.
    Heyser CJ; Moc K; Koob GF
    Neuropsychopharmacology; 2003 Aug; 28(8):1463-71. PubMed ID: 12700689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage.
    Gardell LR; Whalen CA; Chattophadyay S; Cavallaro CA; Hubbell CL; Reid LD
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1435-9. PubMed ID: 9394115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predischarge Injectable Versus Oral Naltrexone to Improve Postdischarge Treatment Engagement Among Hospitalized Veterans with Alcohol Use Disorder: A Randomized Pilot Proof-of-Concept Study.
    Busch AC; Denduluri M; Glass J; Hetzel S; Gugnani SP; Gassman M; Krahn D; Deyo B; Brown R
    Alcohol Clin Exp Res; 2017 Jul; 41(7):1352-1360. PubMed ID: 28605827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density.
    Cowen MS; Rezvani AH; Jarrott B; Lawrence AJ
    Alcohol Clin Exp Res; 1999 Jun; 23(6):1008-14. PubMed ID: 10397284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors.
    Korpi ER; Linden AM; Hytönen HR; Paasikoski N; Vashchinkina E; Dudek M; Herr DR; Hyytiä P
    Addict Biol; 2017 Jul; 22(4):1022-1035. PubMed ID: 26990998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism.
    Sinclair JD
    Alcohol Alcohol; 2001; 36(1):2-10. PubMed ID: 11139409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.
    Krishnan-Sarin S; Krystal JH; Shi J; Pittman B; O'Malley SS
    Biol Psychiatry; 2007 Sep; 62(6):694-7. PubMed ID: 17336941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open-label pilot study of extended-release naltrexone to reduce drinking and driving among repeat offenders.
    Lapham SC; McMillan GP
    J Addict Med; 2011 Sep; 5(3):163-9. PubMed ID: 21844831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
    Anton RF; Moak DH; Waid LR; Latham PK; Malcolm RJ; Dias JK
    Am J Psychiatry; 1999 Nov; 156(11):1758-64. PubMed ID: 10553740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low doses of naltrexone reduce palatability and consumption of ethanol in outbred rats.
    Coonfield DL; Hill KG; Kaczmarek HJ; Ferraro FM; Kiefer SW
    Alcohol; 2002 Jan; 26(1):43-7. PubMed ID: 11958946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans.
    Sofuoglu M; Singha A; Kosten TR; McCance-Katz FE; Petrakis I; Oliveto A
    Pharmacol Biochem Behav; 2003 Jul; 75(4):801-8. PubMed ID: 12957222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naltrexone and alcohol dependence. Role of subject compliance.
    Volpicelli JR; Rhines KC; Rhines JS; Volpicelli LA; Alterman AI; O'Brien CP
    Arch Gen Psychiatry; 1997 Aug; 54(8):737-42. PubMed ID: 9283509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ethanol drinking and naltrexone on subsequent drinking in rats.
    Davidson D; Amit Z
    Alcohol; 1997; 14(6):581-4. PubMed ID: 9401674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats.
    Perfumi M; Mattioli L; Cucculelli M; Massi M
    J Psychopharmacol; 2005 Sep; 19(5):448-54. PubMed ID: 16166181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does family history of alcoholism moderate naltrexone's effects on alcohol use?
    Capone C; Kahler CW; Swift RM; O'Malley SS
    J Stud Alcohol Drugs; 2011 Jan; 72(1):135-40. PubMed ID: 21138720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Ralevski E; Rounsaville B
    Biol Psychiatry; 2006 Oct; 60(7):777-83. PubMed ID: 17008146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.
    Kahler CW; Cioe PA; Tzilos GK; Spillane NS; Leggio L; Ramsey SE; Brown RA; O'Malley SS
    Alcohol Clin Exp Res; 2017 Jun; 41(6):1201-1211. PubMed ID: 28401564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.